Question Bank › Questions aim low, answers land high

Questions aim low, answers land high

Questions aim low, answers land high: the dialogue keeps correcting expectations upward with facts already in hand

Calls Tested
499
Answered YES
67
Hit Rate
13.4%
rare by design

ANI Pharmaceuticals, Inc. (ANIP) — this company's answers

NO on the Q4 2016 call 2017-03-02 B+
The model's full reasoning — Q4 2016 call → NOWe need to determine if there is a clear, recurring mismatch in level between questioners' assumptions and management's reported reality, with the mismatch running upward (analysts more cautious, management correcting upward with concrete facts). Let's analyze the Q&A exchanges. The call has three analysts: Louise Chen (Guggenheim), Elliot Wilbur (Raymond James), Scott Henry (ROTH Capital). Let's go through each exchange. 1. Louise Chen's first question: "just curious, now that you have changed the company quite a bit and moved away from EEMT, what is your strategic vision for ANI? And what do you want to do to get there? And how long will it take you?" This is a broad strategic question, not necessarily cautious. Management answers with vision, mentions $100 million EBITDA goal, corticotrophin potential. Not a clear mismatch. 2. Louise Chen's second question: "just I guess as you talked about corticotrophin, on the questions that we get a lot is whether or not you have met with the FDA? And if not, do you think you need to before the NDA can be revised?" This is a cautious question about regulatory progress. Management answers: "We have not met with the FDA. As you have seen we have recently hired Dr. Karen Quinn to lead the regulatory strategy and meetings with FDA and eventual filings of an sNDA for us. And we absolutely will need to meet with the FDA before we file the sNDA, so they understand our approach, what they will be receiving in the sNDA filing. And we have an opportunity to discuss that with the." This is management confirming they haven't met, but they have hired someone and will need to meet. This is not an upward correction; it's a confirmation of a step. Not a mismatch. 3. Louise Chen's third question: "just on M&A. I know that you said that you have sources to additional capital. But just curious, what areas interest you the most? And could you give any color on the size of the details that you would like to do here?" Management answers with a general discussion of M&A strategy, not correcting upward. No mismatch. So Louise Chen's questions are not particularly cautious or below the business. They are neutral. Now Elliot Wilbur's questions: First question: "You had mentioned an item that had negatively impacted revenue in the fourth quarter in terms of hurting the sequential comp. And I apologize, I didn't catch exactly what that was.

← Back to the full ANIP analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: Reading this call as a whole, is there a clear, recurring MISMATCH IN LEVEL between what the questioners assume about the company and what management reports is actually happening — with the mismatch running in the UPWARD direction — such that analysts' questions are framed around a more modest, more cautious, or more troubled version of the business, and management repeatedly answers by correcting that frame UPWARD using concrete things that have ALREADY happened or are ALREADY happening? Answer YES when BOTH halves of this one dynamic come through across the call, in whatever form fits the business: (1) THE QUESTIONS SIT BELOW THE BUSINESS. Across multiple exchanges — not just one — the analysts' questions are premised on a lower or more guarded picture of the company than management's account supports: probing whether recent strength can hold or must fade, asking about risks, slowdowns, competition, funding, or problems that management's answers show are not what the business is currently experiencing, sizing the company's prospects around its old level or old story, or treating as uncertain things management describes as already settled. The cautious framing may be polite, routine, or skeptical in tone — what matters is that the expectations embedded in the questions run BELOW what the answers reveal. (2) MANAGEMENT CORRECTS UPWARD WITH THINGS ALREADY REAL. In responding, management does not merely reassure, promise, or express confidence — it repeatedly answers the cautious premise by pointing to concrete, present-tense or just-happened operating facts that exceed it: actual orders, customers, volumes, activity, output, utilization, commitments, or operational progress already occurring, described with enough specificity (who, what, how much, how recently, or what changed) that the correction rests on observed reality rather than on outlook language. The overall effect of the call is that a reader watching only the dialogue sees the company's actual current level repeatedly coming in ABOVE where the questioners had placed it, with management conveying — directly or plainly in substance — that this stronger current reality is continuing rather than concluded. Answer NO if the questions and answers sit at the same level — analysts and management sharing one picture of the business, whether good or bad. NO if the analysts' expectations run ABOVE the business, with management talking enthusiasm down, hedging, or conceding weakness. NO if management's corrections rest mainly on plans, guidance, pipeline, market size, or confidence rather than on things already happening. NO if the upward correction occurs in only a single exchange while the rest of the call is aligned. NO if management corrects the frame with one-time items, windfalls, or conditions it itself expects to reverse. NO if the reported period is weak and management is chiefly excusing it or promising a turnaround. NO if there is no substantive question-and-answer dialogue in the transcript from which the mismatch can be judged. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
FWONK Formula One Group Q1 2024 2024-05-08 C+
AZEK The AZEK Company Inc. Q2 2024 2024-05-08 B+
AES The AES Corporation Q1 2024 2024-05-03 C+
WEC WEC Energy Group, Inc. Q1 2024 2024-05-01 A
PDS Precision Drilling Corporation Q1 2024 2024-04-25 B
GL Globe Life Inc. Q1 2024 2024-04-23 F
GIII G-III Apparel Group, Ltd. Q4 2024 2024-03-14 C
NICE NICE Ltd. Q4 2023 2024-02-22 B+
EGP EastGroup Properties, Inc. Q4 2023 2024-02-08 B
DASH DoorDash, Inc. Q3 2023 2023-11-01 C+
SITM SiTime Corporation Q2 2023 2023-08-02 C+
ET Energy Transfer LP Q2 2023 2023-08-02 C+
AFL Aflac Incorporated Q2 2023 2023-08-02 C+
SLF Sun Life Financial Inc. Q1 2023 2023-05-12 B
SPIR Spire Global, Inc. Q1 2023 2023-05-10 B
KE Kimball Electronics, Inc. Q3 2023 2023-05-06 C+
SBRA Sabra Health Care REIT, Inc. Q1 2023 2023-05-04 B
BRX Brixmor Property Group Inc. Q1 2023 2023-05-02 A
TACT TransAct Technologies Incorporated Q4 2022 2023-03-08 A
DKS DICK'S Sporting Goods, Inc. Q4 2022 2023-03-07 B
TOST Toast, Inc. Q4 2022 2023-02-16 C+
ADPT Adaptive Biotechnologies Corporation Q4 2022 2023-02-14 C+
ADM Archer-Daniels-Midland Company Q4 2022 2023-01-26 C+
HBAN Huntington Bancshares Incorporated Q4 2022 2023-01-20 B
UAL United Airlines Holdings, Inc. Q4 2022 2023-01-18 B
ICL ICL Group Ltd Q3 2022 2022-11-09 B+
SYY Sysco Corporation Q1 2023 2022-11-01 C+
FLR Fluor Corporation Q2 2022 2022-08-05 D
CRL Charles River Laboratories International Q2 2022 2022-08-03 C
HLNE Hamilton Lane Incorporated Q1 2023 2022-08-02 C+
SGRY Surgery Partners, Inc. Q2 2022 2022-08-02 B+
IT Gartner, Inc. Q2 2022 2022-08-02 A
LIN Linde plc Q2 2022 2022-07-28 B+
CME CME Group Inc. Q2 2022 2022-07-27 B
PRGS Progress Software Corporation Q2 2022 2022-06-28 B+
KFY Korn Ferry Q4 2022 2022-06-22 B
BHF Brighthouse Financial, Inc. Q1 2022 2022-05-10 C
VVV Valvoline Inc. Q1 2022 2022-02-09 C+
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
MD Pediatrix Medical Group, Inc. Q3 2021 2021-10-28 B
LOPE Grand Canyon Education, Inc. Q2 2021 2021-08-08 C
T AT&T Inc. Q3 2018 2018-10-24 C+
STM STMicroelectronics NV Q3 2018 2018-10-24 C+
TMHC Taylor Morrison Home Corporation Q2 2018 2018-08-01 B
ORAN Orange SA Q2 2018 2018-07-26 B
KIM Kimco Realty Corporation Q2 2018 2018-07-26 B+
HPE Hewlett Packard Enterprise Company Q2 2018 2018-05-22 B+
LAUR Laureate Education, Inc. Q1 2018 2018-05-13 B+
SATS EchoStar Corporation Q1 2018 2018-05-10 C+
ALLY Ally Financial Inc. Q1 2018 2018-04-26 B+
KRG Kite Realty Group Trust Q1 2018 2018-04-26 C+
AVT Avnet, Inc. Q2 2018 2018-01-25 B
RACE Ferrari N.V. Q3 2017 2017-11-02 C+
IR Ingersoll-Rand Plc Q3 2017 2017-10-25 B
SNA Snap-on Incorporated Q3 2017 2017-10-19 B
LIND Lindblad Expeditions Holdings, Inc. Q2 2017 2017-08-06 C
CCOI Cogent Communications Holdings, Inc. Q2 2017 2017-08-03 B
LEA Lear Corporation Q2 2017 2017-07-26 B+
DHR Danaher Corporation Q1 2017 2017-04-20 B
CAG Conagra Brands, Inc. Q2 2017 2016-12-22 C+
MAT Mattel, Inc. Q3 2016 2016-10-19 C
CGNX Cognex Corporation Q2 2016 2016-08-01 A
GOGO Gogo Inc. Q1 2016 2016-05-06 C+
DD DuPont de Nemours, Inc. Q1 2016 2016-04-26 B+
HPP Hudson Pacific Properties, Inc. Q4 2015 2016-02-25 C
HD The Home Depot, Inc. Q4 2015 2016-02-23 A
JHX James Hardie Industries plc Q3 2016 2016-02-19 B+

How the model reasoned

GOGO · Q1 2016 → YESThe question is about whether there's a clear, recurring mismatch where analysts assume a more modest/cautious/troubled version, and management corrects UPWARD with things already happening. YES The analysts' questions repeatedly frame the business around cautious or risk-oriented assumptions—such as ARPA trajectory concerns amid competition, cash and liquidity needs, potential sentiment issues with the Gogo brand, and competitive pressures from Panasonic—while management consistently corrects upward by citing concrete, already-realized facts: record revenues, 2Ku now in service on AeroMexico and IAG, over 1,000 planes awarded, Delta increases, install records, and backlog progress already achieved. This pattern repeats across multiple exchanges, with management pointing to present-tense operational realities that exceed the cautious premises embedded in the questions.
LAUR · Q1 2018 → YESThe question is about whether there's a clear, recurring mismatch in level between what the questioners assume and what management reports, with the mismatch running UPWARD. Analysts think more modest...YES The transcript shows a clear recurring mismatch running upward. Analysts repeatedly probe cautious angles—Chile as a potential end rather than final ruling, Brazil FIES exposure as a risk, margin phasing and guidance including divestitures, Turkey as needing update, FCF not raised despite Chile, leverage post-St. Augustine, and Accelerator 2.0 health sciences—framing the business around lingering uncertainties or modest upside.
JHX · Q3 2016 → YESThe question is about whether there's a clear, recurring mismatch where analysts assume a more modest/cautious/troubled version, and management corrects UPWARD with concrete things already happening. ...NO The transcript shows analysts probing for signs of weakness or slowdowns (seasonal margins, destocking, Europe performance, PDG pickup, volumes vs targets), but management repeatedly corrects upward with concrete current facts: strong Q3 margins (2.6 points better), no destocking, plants running well, costs controlled, 12% volume growth, Europe already through the one-off, and inventory normalized.

More from the question bank

Growing out of the old selfFree option on their own operationsTheir own money on the lineRepeat expansion inside the base while new lMid-period crossingsThe company is outgrowing its own explanatioAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.